These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 19453834)
1. Pituitary adenomas can appear as hypermetabolic lesions in (18) F-FDG PET imaging. Ryu SI; Tafti BA; Skirboll SL J Neuroimaging; 2010 Oct; 20(4):393-6. PubMed ID: 19453834 [TBL] [Abstract][Full Text] [Related]
2. High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease. Chittiboina P; Montgomery BK; Millo C; Herscovitch P; Lonser RR J Neurosurg; 2015 Apr; 122(4):791-7. PubMed ID: 25479121 [TBL] [Abstract][Full Text] [Related]
3. All that glitters on PET is not cancer! 18F-deoxy-glucose avidity versus tumor biology: pituitary incidentaloma in a survivor of two previous unrelated malignancies. Miljić D; Manojlović-Gačić E; Skender-Gazibara M; Milojević T; Bogosavljević V; Kozarević N; Petrović N; Stojanović M; Pekić S; Doknić M; Petakov M; Popović V Endokrynol Pol; 2017; 68(3):352-359. PubMed ID: 28660992 [TBL] [Abstract][Full Text] [Related]
4. Analysis of 18F-fluorodeoxyglucose positron emission tomography findings in patients with pituitary lesions. Seok H; Lee EY; Choe EY; Yang WI; Kim JY; Shin DY; Cho HJ; Kim TS; Yun MJ; Lee JD; Lee EJ; Lim SK; Rhee Y Korean J Intern Med; 2013 Jan; 28(1):81-8. PubMed ID: 23346000 [TBL] [Abstract][Full Text] [Related]
5. PET/MRI in the Diagnosis of Hormone-Producing Pituitary Microadenoma: A Prospective Pilot Study. Wang H; Hou B; Lu L; Feng M; Zang J; Yao S; Feng F; Wang R; Li F; Zhu Z J Nucl Med; 2018 Mar; 59(3):523-528. PubMed ID: 28775202 [TBL] [Abstract][Full Text] [Related]
6. Pituitary adenoma detected on FDG positron emission tomography in a patient with mucosa-associated lymphoid tissue lymphoma. Campeau RJ; David O; Dowling AM Clin Nucl Med; 2003 Apr; 28(4):296-8. PubMed ID: 12642707 [TBL] [Abstract][Full Text] [Related]
7. [Value of 18F-FDG and 11C-MET PET-CT in differentiation of brain ringlike-enhanced neoplastic and non-neoplastic lesions on MRI imaging]. Cai L; Gao S; Li DC; Li YS; Chen QS; Xing XL Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):134-8. PubMed ID: 19538892 [TBL] [Abstract][Full Text] [Related]
8. Utility of 11C-Methionine and 18F-FDG PET/CT in Patients With Functioning Pituitary Adenomas. Feng Z; He D; Mao Z; Wang Z; Zhu Y; Zhang X; Wang H Clin Nucl Med; 2016 Mar; 41(3):e130-4. PubMed ID: 26646998 [TBL] [Abstract][Full Text] [Related]
10. 2-(18F)-fluoro-2-deoxy-D-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study. van Kouwen MC; Nagengast FM; Jansen JB; Oyen WJ; Drenth JP J Clin Oncol; 2005 Jun; 23(16):3713-7. PubMed ID: 15923568 [TBL] [Abstract][Full Text] [Related]
11. Preoperative Evaluation of Sellar and Parasellar Macrolesions by [ Tosaka M; Higuchi T; Horiguchi K; Osawa T; Arisaka Y; Fujita H; Tsushima Y; Yoshimoto Y World Neurosurg; 2017 Jul; 103():591-599. PubMed ID: 28427982 [TBL] [Abstract][Full Text] [Related]
12. The pituitary in nuclear medicine imaging. Iglesias P; Cardona J; Díez JJ Eur J Intern Med; 2019 Oct; 68():6-12. PubMed ID: 31519379 [TBL] [Abstract][Full Text] [Related]
13. Clinical application of combination [ Wang Z; Feng Z; Zhu D; Wang X; Chen J; Zhu Y; Wang H BMC Endocr Disord; 2024 Feb; 24(1):19. PubMed ID: 38311763 [TBL] [Abstract][Full Text] [Related]
14. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions. Lan XL; Zhang YX; Wu ZJ; Jia Q; Wei H; Gao ZR Clin Radiol; 2008 Jul; 63(7):756-64. PubMed ID: 18555033 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer. Ozawa Y; Hara M; Sakurai K; Nakagawa M; Tamaki T; Nishio M; Shibamoto Y Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375 [TBL] [Abstract][Full Text] [Related]
16. Incidental pituitary uptake on whole-body 18F-FDG PET/CT: a multicentre study. Jeong SY; Lee SW; Lee HJ; Kang S; Seo JH; Chun KA; Cho IH; Won KS; Zeon SK; Ahn BC; Lee J Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2334-43. PubMed ID: 20661556 [TBL] [Abstract][Full Text] [Related]
17. Incidental colonic focal lesions detected by FDG PET/CT. Gutman F; Alberini JL; Wartski M; Vilain D; Le Stanc E; Sarandi F; Corone C; Tainturier C; Pecking AP AJR Am J Roentgenol; 2005 Aug; 185(2):495-500. PubMed ID: 16037527 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of 18F-fluorodeoxyglucose positron emission tomography in differential diagnosis and staging of cholangiocarcinomas. Moon CM; Bang S; Chung JB; Park SW; Song SY; Yun M; Lee JD J Gastroenterol Hepatol; 2008 May; 23(5):759-65. PubMed ID: 17931372 [TBL] [Abstract][Full Text] [Related]
19. Positron emission tomography for the detection of colorectal adenomas. Ravizza D; Bartolomei M; Santoro L; Tamayo D; Fiori G; Trovato C; De Cicco C; De Roberto G; Paganelli G; Crosta C Dig Liver Dis; 2010 Mar; 42(3):185-90. PubMed ID: 19643688 [TBL] [Abstract][Full Text] [Related]
20. 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. Kim JM; Ryu JS; Kim TY; Kim WB; Kwon GY; Gong G; Moon DH; Kim SC; Hong SJ; Shong YK J Clin Endocrinol Metab; 2007 May; 92(5):1630-4. PubMed ID: 17284624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]